| Financial Year |
March 31 2019 |
| Monetary Funds |
101,206,666.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,731,566.08 |
| Accounts Receivable |
641,538,257.56 |
| Advances to Suppliers |
1,568,537.03 |
| Other Receivables |
631,600,358.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,745,748.51 |
| Dividend Receivable |
622,794.67 |
| Inventories |
8,092,342.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
197,750,413.13 |
| Total Current Assets |
2,319,095,001.26 |
| Available-for-Sale Financial Asset |
252,547,817.50 |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
299,576,023.02 |
| Investment Properties |
-- |
| Fixed Assetes |
3,280,219,114.43 |
| Under-construction Projects |
238,495,492.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
146,088,985.51 |
| R&D expenses |
-- |
| Goodwill |
71,290,577.48 |
| Long-Term Deferred and Prepaid Expenses |
26,942,090.49 |
| Deferred Income Tax Assets |
34,066,614.04 |
| Other Non-Current Assets |
24,532,403.11 |
| Sub-Total of Non-Current Assets |
4,373,759,118.13 |
| Total Assets |
6,692,854,119.39 |
| Short-Term Loans |
942,674,406.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
363,200,680.66 |
| Employee Compensation Payable |
36,174,940.67 |
| Taxes Payable |
80,731,898.05 |
| Interest Payable |
250,314,074.55 |
| Dividend Payable |
-- |
| Other payables |
2,759,930,180.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,363,486,338.64 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
7,480,671,686.76 |
| Long-term Loans |
985,072,865.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
571,996,530.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
449,000,904.66 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,047,670,439.61 |
| Total Liabilities |
9,528,342,126.37 |
| Paid-In Capital(Or Share Stock) |
4,724,935,152.00 |
| Capital Surplus |
1,254,560,771.43 |
| Surplus Reserve |
80,549,743.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-8,782,216,999.74 |
| Minority Stockholder's Interest |
-28,860,771.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,806,627,235.40 |
| Owner's Equity（Stockholder's Equity） |
-2,835,488,006.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,692,854,119.39 |
